VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 173 filers reported holding VERA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 2.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $25,832,520 | -15.6% | 714,000 | +0.6% | 10.54% | -13.0% |
| Q1 2024 | $30,615,200 | +223.7% | 710,000 | +15.4% | 12.12% | +88.7% |
| Q4 2023 | $9,458,700 | +106.8% | 615,000 | +84.3% | 6.42% | +169.1% |
| Q3 2023 | $4,574,767 | +137.5% | 333,681 | +178.1% | 2.39% | +63.6% |
| Q2 2023 | $1,926,000 | -13.2% | 120,000 | -58.0% | 1.46% | +18.3% |
| Q1 2023 | $2,219,360 | – | 286,000 | – | 1.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 714,000 | $25,832,520 | 10.54% |
| COMMODORE CAPITAL LP | 2,475,000 | $89,545,500 | 6.11% |
| Sofinnova Investments, Inc. | 2,793,987 | $101,086,450 | 5.25% |
| Eversept Partners, LP | 2,043,214 | $73,923,483 | 5.06% |
| Portman Ltd | 32,795 | $1,186,523 | 4.48% |
| Kynam Capital Management, LP | 1,543,669 | $55,849,944 | 4.31% |
| First Light Asset Management, LLC | 1,005,723 | $36,387,058 | 3.19% |
| Logos Global Management LP | 950,000 | $34,371,000 | 2.79% |
| Cutter Capital Management, LP | 230,000 | $8,321,400 | 2.51% |
| Avoro Capital Advisors LLC | 4,309,590 | $155,920,966 | 2.08% |